Management guidelines for primary lung cancer 2018: Chinese standards in clinical practice

Chao Lyu, Nan Wu

2019, 31(3): 419-420. doi: 10.21147/j.issn.1000-9604.2019.03.01

Management guidelines for esophageal carcinoma 2018: Chinese standards in clinical practice

Yuan Feng, Nan Wu

2019, 31(3): 421-422. doi: 10.21147/j.issn.1000-9604.2019.03.02

Updates in version 2019 of CSCO guidelines for colorectal cancer from version 2018

Ying Yuan, Xicheng Wang, Gong Chen, Yi Wang, Weiqi Sheng, Xinxiang Li, Aiping Zhou, Zhen Zhang, Guichao Li, Sanjun Cai, Ruihua Xu, Jin Li, Suzhan Zhang

2019, 31(3): 423-425. doi: 10.21147/j.issn.1000-9604.2019.03.03

Incidence and mortality of esophagus cancer in China, 2008−2012

Yutong He, Daojuan Li, Baoen Shan, Di Liang, Jin Shi, Wanqing Chen, Jie He

2019, 31(3): 426-434. doi: 10.21147/j.issn.1000-9604.2019.03.04

Incidence and mortality of corpus uteri cancer in China, 2008−2012

Yunfeng Xi, Wenrui Wang, Wenjie Chen, Ke Han, Liying Qiao, Wanqing Chen

2019, 31(3): 435-442. doi: 10.21147/j.issn.1000-9604.2019.03.05

A comparison of short-term postoperative outcomes including nutritional status between gastrectomy with simultaneous cholecystectomy and gastrectomy only in patients with gastric cancer

You Na Kim, Ji Yeong An, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Sung Kim

2019, 31(3): 443-452. doi: 10.21147/j.issn.1000-9604.2019.03.06

Predictive values of multidetector-row computed tomography combined with serum tumor biomarkers in preoperative lymph node metastasis of gastric cancer

Huihui Bai, Jingyu Deng, Nannan Zhang, Huifang Liu, Wenting He, Jinyuan Liu, Han Liang

2019, 31(3): 453-461. doi: 10.21147/j.issn.1000-9604.2019.03.07

Immune signature profiling identified prognostic factors for gastric cancer

Wenhui Yang, Zhiyong Lai, Yuan Li, Jianbing Mu, Mudan Yang, Jun Xie, Jun Xu

2019, 31(3): 463-470. doi: 10.21147/j.issn.1000-9604.2019.03.08

Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping

Xiangcheng Zhi, Xiaonan Yang, Teng Pan, Jingjing Liu, Xiao Chen, Liping Lou, Zhendong Shi, Jin Zhang

2019, 31(3): 471-480. doi: 10.21147/j.issn.1000-9604.2019.03.09

Impact of crizotinib on long-term survival of ALK-positive advanced non-small-cell lung cancer: A Chinese multicenter cohort study

Puyuan Xing, Di Ma, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li

2019, 31(3): 481-488. doi: 10.21147/j.issn.1000-9604.2019.03.10

Burden of colorectal cancer in China, 1990−2017: Findings from the Global Burden of Disease Study 2017

Jie Yin, Zhigang Bai, Jun Zhang, Zhi Zheng, Hongwei Yao, Pengpeng Ye, Jun Li, Xin Gao, Zhongtao Zhang

2019, 31(3): 489-498. doi: 10.21147/j.issn.1000-9604.2019.03.11

Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression

Hongpeng Jiang, Boxi Kang, Xinmei Huang, Yichao Yan, Shan Wang, Yingjiang Ye, Zhanlong Shen

2019, 31(3): 499-510. doi: 10.21147/j.issn.1000-9604.2019.03.12

Adjuvant hormone therapy after radical prostatectomy in high-risk localized and locally advanced prostate cancer: First multicenter, observational study in China

Dingwei Ye, Wei Zhang, Lulin Ma, Chuanjun Du, Liping Xie, Yiran Huang, Qiang Wei, Zhangqun Ye, Yanqun Na

2019, 31(3): 511-520. doi: 10.21147/j.issn.1000-9604.2019.03.13

Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase

Fangxiu Luo, You Li, Fei Yuan, Junli Zuo

2019, 31(3): 521-532. doi: 10.21147/j.issn.1000-9604.2019.03.14

Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis

Qiang Ju, Lina Zhao, Jiajia Gao, Lanping Zhou, Yang Xu, Yulin Sun, Xiaohang Zhao

2019, 31(3): 533-546. doi: 10.21147/j.issn.1000-9604.2019.03.15

Prognostic significance of periostin in colorectal cancer

Xingming Deng, Sheng Ao, Jianing Hou, Zhuofei Li, Yunpeng Lei, Guoqing Lyu

2019, 31(3): 547-556. doi: 10.21147/j.issn.1000-9604.2019.03.16